Search

Your search keyword '"Scalais, Emmanuel"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Scalais, Emmanuel" Remove constraint Author: "Scalais, Emmanuel"
164 results on '"Scalais, Emmanuel"'

Search Results

2. Adaptive behavior and psychiatric comorbidities in KCNB1 encephalopathy

3. Clinical delineation, sex differences, and genotype–phenotype correlation in pathogenic KDM6A variants causing X-linked Kabuki syndrome type 2

5. TREX‐1 related Aicardi‐Goutières syndrome improved by Janus kinase inhibitor.

6. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.

7. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5

8. Loss of function of NCOR1 and NCOR2 impairs memory through a novel GABAergic hypothalamus–CA3 projection

10. FOSL2 truncating variants in the last exon cause a neurodevelopmental disorder with scalp and enamel defects

12. Rare pathogenic variants in WNK3 cause X-linked intellectual disability

15. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

16. FOSL2 truncating variants in the last exon cause a neurodevelopmental disorder with scalp and enamel defects

17. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

18. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

19. Author Correction: Loss of function of NCOR1 and NCOR2 impairs memory through a novel GABAergic hypothalamus–CA3 projection

20. Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders

21. Understanding the new BRD4‐related syndrome: Clinical and genomic delineation with an international cohort study

22. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

25. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

26. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

27. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications

28. FOSL2truncating variants in the last exon cause a neurodevelopmental disorder with scalp and enamel defects

29. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome.

31. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long‐term outcome

32. De novo missense variants in LMBRD2 are associated with developmental and motor delays, brain structure abnormalities and dysmorphic features

33. An Overview of L-2-Hydroxyglutarate Dehydrogenase Gene (L2HGDH) Variants: A Genotype–Phenotype Study

34. Duplications of the critical Rubinstein–Taybi deletion region on chromosome 16p13.3 cause a novel recognisable syndrome

35. Parenteral hydroxocobalamin dose intensification in five patients with different types of early onset intracellular cobalamin defects : Clinical and biochemical responses

36. Parenteral hydroxocobalamin dose intensification in five patients with different types of early onset intracellular cobalamin defects: Clinical and biochemical responses

37. De novo missense variants in LMBRD2 are associated with developmental and motor delays, brain structure abnormalities and dysmorphic features.

38. Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature

39. Parenteral hydroxocobalamin dose intensification in five patients with different types of early onset intracellular cobalamin defects: Clinical and biochemical responses

40. Clinical delineation, sex differences, and genotype–phenotype correlation in pathogenic KDM6Avariants causing X-linked Kabuki syndrome type 2

41. Autosomal-dominant early-onset spastic paraparesis with brain calcification due to IFIH1 gain-of-function

42. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

43. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

44. De novo missense variants in LMBRD2are associated with developmental and motor delays, brain structure abnormalities and dysmorphic features

45. X-Linked Cobalamin Disorder ( HCFC1 ) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid

46. Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway (P5.136)

47. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

48. Author Correction: Loss of function of NCOR1 and NCOR2 impairs memory through a novel GABAergic hypothalamus–CA3 projection

49. Shwachman–Diamond syndrome presenting with early ichthyosis, associated dermal and epidermal intracellular lipid droplets, hypoglycemia, and later distinctive clinical SDS phenotype

50. Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway

Catalog

Books, media, physical & digital resources